Free Trial

Guardant Health (GH) News Today

Guardant Health logo
$46.46 -0.28 (-0.60%)
Closing price 04:00 PM Eastern
Extended Trading
$46.32 -0.15 (-0.31%)
As of 05:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Guardant Health, Inc. stock logo
Cibc World Markets Corp Makes New Investment in Guardant Health, Inc. (NASDAQ:GH)
Cibc World Markets Corp acquired a new stake in Guardant Health, Inc. (NASDAQ:GH - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 11,342 shares of the company's stock, valued at approx
Guardant Health, Inc. stock logo
20,609 Shares in Guardant Health, Inc. (NASDAQ:GH) Purchased by Summit Global Investments
Summit Global Investments bought a new position in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 20,609 shares of the company's stock, valued at approximately $63
Guardant Health, Inc. stock logo
Guardant Health, Inc. (NASDAQ:GH) Stock Holdings Boosted by Intech Investment Management LLC
Intech Investment Management LLC lifted its position in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 33.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 43,824 shares of the company's stock after acquiring an additional 10,976 shares during
Guardant Health, Inc. stock logo
Primecap Management Co. CA Lowers Stock Holdings in Guardant Health, Inc. (NASDAQ:GH)
Primecap Management Co. CA lessened its stake in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 34.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 43,686 shares of the company's stock after selling 2
Craig-Hallum Sticks to Its Buy Rating for Guardant Health (GH)
Guardant Health, Inc. stock logo
Nikko Asset Management Americas Inc. Has $44.73 Million Stock Position in Guardant Health, Inc. (NASDAQ:GH)
Nikko Asset Management Americas Inc. raised its holdings in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 15.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,464,213 shares of the company's stock after acquiring an additional 197,729 shar
Guardant Health, Inc. stock logo
Charles Schwab Investment Management Inc. Increases Holdings in Guardant Health, Inc. (NASDAQ:GH)
Charles Schwab Investment Management Inc. lifted its position in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,016,533 shares of the company's stock after purchasing an additional 13,395 sha
Guardant Health, Inc. stock logo
Traders Purchase High Volume of Call Options on Guardant Health (NASDAQ:GH)
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) was the recipient of some unusual options trading activity on Friday. Investors acquired 4,097 call options on the stock. This represents an increase of approximately 78% compared to the average volume of 2,301 call options.
Guardant Health, Inc. stock logo
Erste Asset Management GmbH Sells 240,000 Shares of Guardant Health, Inc. (NASDAQ:GH)
Erste Asset Management GmbH reduced its position in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 25.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 692,600 shares of the company's stoc
Guardant Health (GH) Receives a Buy from Barclays
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Trading Up 9.8% - What's Next?
Guardant Health (NASDAQ:GH) Trading Up 9.8% - Here's Why
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Trading Down 9.5% - Should You Sell?
Guardant Health (NASDAQ:GH) Stock Price Down 9.5% - Here's What Happened
Guardant Health, Inc. stock logo
Bank of New York Mellon Corp Reduces Stock Holdings in Guardant Health, Inc. (NASDAQ:GH)
Bank of New York Mellon Corp lowered its holdings in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 5.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 899,902 shares of the company's stock after selling 49,309
Guardant Health, Inc. stock logo
Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Candriam S.C.A.
Candriam S.C.A. lessened its stake in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 3.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 352,492 shares of the company's stock after selling 13,653 shares during the period. Candriam S.C.A. owned about 0.29% o
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Stock Price Expected to Rise, Morgan Stanley Analyst Says
Morgan Stanley boosted their target price on shares of Guardant Health from $42.00 to $52.00 and gave the company an "overweight" rating in a report on Thursday.
Guardant Health, Inc. stock logo
Aigen Investment Management LP Acquires 6,854 Shares of Guardant Health, Inc. (NASDAQ:GH)
Aigen Investment Management LP lifted its position in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 35.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,957 shares of the company
Guardant Health, Inc. stock logo
Guardant Health, Inc. (NASDAQ:GH) Sees Significant Growth in Short Interest
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) was the target of a significant increase in short interest in February. As of February 15th, there was short interest totalling 7,840,000 shares, an increase of 35.9% from the January 31st total of 5,770,000 shares. Based on an average daily trading volume, of 2,130,000 shares, the days-to-cover ratio is currently 3.7 days.
Guardant Health, Inc. stock logo
Guardant Health, Inc. (NASDAQ:GH) Shares Purchased by SWS Partners
SWS Partners boosted its holdings in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 44.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 120,888 shares of the company's stock after purchasing an additional
Guardant Health, Inc. stock logo
Guardant Health, Inc. (NASDAQ:GH) Given Average Rating of "Buy" by Analysts
Shares of Guardant Health, Inc. (NASDAQ:GH - Get Free Report) have been assigned a consensus recommendation of "Buy" from the nineteen analysts that are presently covering the company, Marketbeat.com reports. Nineteen investment analysts have rated the stock with a buy rating. The average 12-month
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Stock Price Expected to Rise, Piper Sandler Analyst Says
Piper Sandler lifted their price target on shares of Guardant Health from $34.00 to $50.00 and gave the company an "overweight" rating in a research report on Wednesday.
Piper Sandler Keeps Their Buy Rating on Guardant Health (GH)
Guardant Health price target raised to $50 from $34 at Piper Sandler
Guardant Health, Inc. stock logo
ARK Investment Management LLC Trims Stock Position in Guardant Health, Inc. (NASDAQ:GH)
ARK Investment Management LLC lowered its stake in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 4.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 1,439,852 shares of the company's stock after selling 72,842 shares during the period. ARK
Guardant Health price target raised to $52 from $47 at Scotiabank
Guardant Health price target raised to $60 from $42 at Canaccord
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Stock Price Expected to Rise, Scotiabank Analyst Says
Scotiabank boosted their price target on Guardant Health from $47.00 to $52.00 and gave the company a "sector outperform" rating in a research report on Monday.
Guardant Health, Inc. stock logo
Guggenheim Reaffirms Buy Rating for Guardant Health (NASDAQ:GH)
Guggenheim reaffirmed a "buy" rating and set a $56.00 price objective on shares of Guardant Health in a research note on Monday.
Guardant Health, Inc. stock logo
Canaccord Genuity Group Forecasts Strong Price Appreciation for Guardant Health (NASDAQ:GH) Stock
Canaccord Genuity Group lifted their price target on Guardant Health from $42.00 to $60.00 and gave the company a "buy" rating in a research note on Monday.
Guardant Health, Inc. stock logo
D.A. Davidson & CO. Boosts Stock Holdings in Guardant Health, Inc. (NASDAQ:GH)
D.A. Davidson & CO. raised its holdings in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 72.1% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 42,380 shares of the company's stock after purchasing an additional 17,755 shares during the peri
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Price Target Raised to $56.00
The Goldman Sachs Group boosted their price target on shares of Guardant Health from $49.00 to $56.00 and gave the stock a "buy" rating in a research report on Friday.
Guardant Health price target raised to $53 from $45 at Stifel
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Shares Down 6.9% Following Weak Earnings
Guardant Health (NASDAQ:GH) Shares Down 6.9% on Disappointing Earnings
Guardant Health, Inc. stock logo
Guardant Health's (GH) Outperform Rating Reiterated at Raymond James
Raymond James restated an "outperform" rating and issued a $59.00 price target (up from $39.00) on shares of Guardant Health in a research report on Friday.
Guardant Health, Inc. stock logo
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Guardant Health (NASDAQ:GH) Stock
JPMorgan Chase & Co. lifted their price target on Guardant Health from $50.00 to $55.00 and gave the company an "overweight" rating in a report on Friday.
Guardant Health, Inc. stock logo
Guardant Health (NASDAQ:GH) Given New $53.00 Price Target at Stifel Nicolaus
Stifel Nicolaus raised their target price on Guardant Health from $45.00 to $53.00 and gave the company a "buy" rating in a research report on Friday.
Guardant Health price target raised to $60 from $55 at BTIG
Remove Ads
Get Guardant Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter.

GH Media Mentions By Week

GH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GH
News Sentiment

0.99

0.62

Average
Medical
News Sentiment

GH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GH Articles
This Week

7

7

GH Articles
Average Week

Remove Ads
Get Guardant Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:GH) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners